CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- 4 Open-market sale SVP & Chief Accounting Officer sold 724 shares at $13.58 ($9,832)
- 4 Open-market sale Director sold 15,000 shares at $16.27 ($244,050)
- 4 Open-market sale SVP & Chief Accounting Officer sold 15,000 shares at $11.79 ($176,850)
- 4 Open-market sale SVP & Chief Medical Officer sold 556 shares at $11.92 ($6,628)
- 4 Open-market sale SVP & Chief Financial Officer sold 963 shares at $11.92 ($11,479)
- 4 Open-market sale President & CEO sold 2,147 shares at $11.92 ($25,592)
- 4 Open-market sale SVP & Chief Scientific Officer sold 390 shares at $11.92 ($4,649)
- 4 Open-market sale SVP & Chief Accounting Officer sold 716 shares at $11.92 ($8,535)
- 4 Open-market sale SVP & General Counsel sold 827 shares at $11.92 ($9,858)
- 4 Open-market sale SVP Pharma Dev & Mfg Ops sold 963 shares at $11.92 ($11,479)
- 4 Open-market sale SVP & General Counsel sold 11,666 shares at $11.49 ($134,042)
- 4 Open-market sale SVP & Chief Accounting Officer sold 15,000 shares at $11.49 ($172,350)
- 4 Open-market sale President & CEO sold 66,666 shares at $11.49 ($765,992)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale SVP & Chief Accounting Officer sold 15,000 shares at $14.12 ($211,800)
- 4 Open-market sale President & CEO sold 66,667 shares at $14.12 ($941,338)
- 4 Open-market sale Director sold 15,000 shares at $14.51 ($217,650)
- 4 Insider Changes in Ownership
- 4/A Insider Changes in Ownership
- 4/A Insider Changes in Ownership
Page 26 of 49 · 970 filings